Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Mar 31;13(3):473-475.
doi: 10.21037/tau-23-606. Epub 2024 Mar 11.

Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer

Thomas Paul Scherer  1 , Cédric Poyet  1
Affiliations
Editorial

Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer

Thomas Paul Scherer et al. Transl Androl Urol. .
No abstract available

Keywords: Screening; prostate cancer (PCa); prostate-specific antigen (PSA).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-606/coif). T.P.S. reports study fees for the Master in Public Health, University Zurich, Basel and Bern from Monsol Foundation and payment for laboratory equipment from the Swiss Cancer Foundation. The other author has no conflicts of interest to declare.

Comment on

References

    1. Schröder FH, Hugosson J, Carlsson S, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52. 10.1016/j.eururo.2012.05.068 - DOI - PubMed
    1. Hugosson J, Roobol MJ, Månsson M, et al. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer. Eur Urol 2019;76:43-51. 10.1016/j.eururo.2019.02.009 - DOI - PMC - PubMed
    1. Gulati R, Tsodikov A, Wever EM, et al. The impact of PLCO control arm contamination on perceived PSA screening efficacy. Cancer Causes Control 2012;23:827-35. 10.1007/s10552-012-9951-8 - DOI - PMC - PubMed
    1. Remmers S, Bangma CH, Godtman RA, et al. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer. Eur Urol 2023;84:503-9. 10.1016/j.eururo.2023.03.031 - DOI - PMC - PubMed
    1. Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009;360:1320-8. 10.1056/NEJMoa0810084 - DOI - PubMed